| “It's driving her mad”: Gender differences in the effects of commuting on psychological health J Roberts, R Hodgson, P Dolan Journal of health economics 30 (5), 1064-1076, 2011 | 420 | 2011 |
| The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal R Hettle, M Corbett, S Hinde, R Hodgson, J Jones-Diette, N Woolacott, ... Health technology assessment 21 (7), 1-204, 2017 | 134 | 2017 |
| Systematic review of 3D mammography for breast cancer screening R Hodgson, SH Heywang-Köbrunner, SC Harvey, M Edwards, J Shaikh, ... The Breast 27, 52-61, 2016 | 85 | 2016 |
| Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK K Lobotesis, R Veltkamp, IH Carpenter, LM Claxton, JL Saver, R Hodgson Journal of medical economics 19 (8), 785-794, 2016 | 76 | 2016 |
| “Spin” in wound care research: the reporting and interpretation of randomized controlled trials with statistically non-significant primary outcome results or unspecified … S Lockyer, R Hodgson, JC Dumville, N Cullum Trials 14, 1-10, 2013 | 65 | 2013 |
| Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis. M Rodgers, D Marshall, M Simmonds, A Le Couteur, M Biswas, K Wright, ... Health Technology Assessment (Winchester, England) 24 (35), 1, 2020 | 62 | 2020 |
| Intensive behavioural interventions based on applied behaviour analysis for young children with autism: An international collaborative individual participant data meta-analysis M Rodgers, M Simmonds, D Marshall, R Hodgson, LA Stewart, D Rai, ... Autism 25 (4), 1137-1153, 2021 | 40 | 2021 |
| Funding source and the quality of reports of chronic wounds trials: 2004 to 2011 R Hodgson, R Allen, E Broderick, JM Bland, JC Dumville, R Ashby, ... Trials 15, 1-10, 2014 | 36 | 2014 |
| A methodological review of recent meta-analyses has found significant heterogeneity in age between randomized groups L Clark, C Fairhurst, CE Hewitt, Y Birks, S Brabyn, S Cockayne, ... Journal of clinical epidemiology 67 (9), 1016-1024, 2014 | 35 | 2014 |
| Party leaders as movers and shakers in British campaigns? Results from the 2010 election D Stevens, JA Karp, R Hodgson The UK General Election of 2010, 6-25, 2013 | 34 | 2013 |
| Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview N Woolacott, M Corbett, J Jones-Diette, R Hodgson Journal of clinical epidemiology 90, 108-118, 2017 | 33 | 2017 |
| A review of issues affecting the efficiency of decision making in the NICE single technology appraisal process MJ Walton, J O’Connor, C Carroll, L Claxton, R Hodgson PharmacoEconomics-open 3, 403-410, 2019 | 32 | 2019 |
| Bandwagon effects in British elections, 1885–1910 R Hodgson, J Maloney Public Choice 157, 73-90, 2013 | 29 | 2013 |
| Tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years: an evidence review group perspective of a NICE … M Walton, S Sharif, M Simmonds, L Claxton, R Hodgson Pharmacoeconomics 37 (10), 1209-1217, 2019 | 26 | 2019 |
| It’s driving her mad: gender differences in the effects of commuting on psychological well-being J Roberts, R Hodgson, P Dolan Department of Economics, University of Sheffield, 2009 | 20 | 2009 |
| Management of patients presenting to the emergency department with sudden onset severe headache: systematic review of diagnostic accuracy studies M Walton, R Hodgson, A Eastwood, M Harden, J Storey, T Hassan, ... Emergency Medicine Journal 39 (11), 818-825, 2022 | 18 | 2022 |
| EMA and NICE appraisal processes for cancer drugs: current status and uncertainties R Dickson, A Boland, R Duarte, E Kotas, N Woolacott, R Hodgson, ... Applied Health Economics and Health Policy 16, 429-432, 2018 | 18 | 2018 |
| Simulation modelling in ophthalmology: application to cost effectiveness of ranibizumab and aflibercept for the treatment of wet age-related macular degeneration in the United … L Claxton, R Hodgson, M Taylor, B Malcolm, R Pulikottil Jacob Pharmacoeconomics 35, 237-248, 2017 | 18 | 2017 |
| Intensive behavioural interventions based on applied behaviour analysis (ABA) for young children with autism: A cost-effectiveness analysis R Hodgson, M Biswas, S Palmer, D Marshall, M Rodgers, L Stewart, ... Plos one 17 (8), e0270833, 2022 | 16 | 2022 |
| Exploring heterogeneity in histology-independent technologies and the implications for cost-effectiveness P Murphy, L Claxton, R Hodgson, D Glynn, L Beresford, M Walton, ... Medical Decision Making 41 (2), 165-178, 2021 | 16 | 2021 |
